Navigation Links
Texcel Introduces Innovative Programmable, Implantable Stimulation System for R&D of Specialty Stimulation Therapies
Date:10/29/2008

EAST LONGMEADOW, Mass., Oct. 29 /PRNewswire/ -- Texcel, a leading provider of custom medical device development and manufacturing solutions, has introduced its innovative new StimX programmable, implantable stimulation system.

Designed for use in the research and development of specialty stimulation therapies, the StimX system is the industry's first-truly programmable, implantable customizable platform.

The StimX system's programmable stimulation parameters "will directly benefit medical researchers and medical device developers by dramatically reducing the time, cost, and risk involved in creating devices for use in testing stimulation therapies in a variety of applications," said Keith Checca, Texcel Director of Business Development.

"With the StimX implantable system, we are freeing researchers from the hours and dollars that they'd otherwise invest in designing and developing their own devices -- and to literally re-allocate their resources back into their research," said Checca.

Neural stimulation therapies, including direct nerve and brain stimulation, are used to treat people who suffer from epilepsy, Parkinson's disease, clinical depression and other diseases. Targeted stimulation areas range widely from direct brain surface, deep brain stimulation, to the spinal cord and peripheral nerves.

Texcel's new StimX platform includes an implantable stimulator, laptop and output customization program, proven wireless communication and charging modules.

The need for the system was realized as a result of Texcel's years of innovation in the field of custom medical device manufacturing and it was made possible by Texcel's partnerships with medical electronics development resources.

For more information, visit the Texcel website at: http://www.texcelmedical.com/stimx; or call the company at (413) 525-5700.

About Texcel

For more than 21 years, Texcel has partnered successfully with companies around the globe to accelerate the commercialization of their implantable, surgical, and interventional medical device technologies. Texcel is staffed with over fifty (50) talented, experienced, and passionate medical device industry employees within an ISO 13485 and ISO 9001 environment. Texcel provides specialized services and/or full medical device solutions including device design, development history file maintenance, quality (QA & QC), regulatory assistance, process validation, and general manufacturing, electronic testing, laser welding, and clean-room packaging for a wide range of product applications. Texcel is based in East Longmeadow, Mass. Visit Texcel on the Net at: http://www.texcelmedical.com.

Download high resolution images for publication from: http://www.flickr.com/photos/10956940@N08/2943759305/


'/>"/>
SOURCE Texcel
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Delta Dental of Illinois Introduces Smile Smart For Your Health
2. Highmark Blue Cross Blue Shield Introduces New Health Plan Comparison Tool for Consumers
3. Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers
4. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
5. GladRags Introduces the Moon Cup - An Environmentally-Sound and Safe Alternative to Disposable Feminine Hygiene Products!
6. Triveris Introduces Personal Health Record with Built-in Health Advisor
7. Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region
8. Mecklenburg EMS Introduces Most-Advanced Situational Training in America for Emergency Medical Personnel
9. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
10. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
11. ThermoTx Introduces New Mobile Stimulation (TENS) Product Line for On the Go Therapy and Pain Relief
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... ... Fisher House Foundation Chairman and CEO Kenneth Fisher joined Governor Brian Sandoval, ... Scott Bensing, and Peggy Kearns Director, VA Southern Nevada Healthcare System yesterday to dedicate ... be the first Fisher House in Nevada, and will provide free lodging for families ...
(Date:2/12/2016)... ... 2016 , ... Young Asset Protection, a full service insurance ... latest charity campaign in their community enrichment program. Art Expression utilizes after-school programs ... are currently being accepted at: http://artexpressioninc.org/ . , Art Expression is a ...
(Date:2/12/2016)... ... 12, 2016 , ... Mediaplanet today announces the launch of ... of “Revolutionizing Cancer Care” is distributed within the February 12 issue of USA ... circulation of approximately 250,000 copies and an estimated readership of 750,000 readers. The ...
(Date:2/12/2016)... ... 12, 2016 , ... A lot has been reported about the fitness routines ... to health and wellness resources most Americans could ever dream of having at their ... schedule as frenetic as the U.S. President. , In honor of President’s Day ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... Basketball is ... and integral part of the Peety PoppersTM series, sign language translation is featured in ... of health and wellness in Peety PoppersTM lessons has a sign language translator to ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... , Feb. 12, 2016 On Thursday, Feb. ... Surgery at St. David,s North Austin Medical Center successfully ... ® Xi ® Surgical System with Trumpf ... Thiru Lakshman , M.D., colorectal surgeon at ... proctocolectomy utilizing Integrated Table Motion technology, which seamlessly combines ...
(Date:2/12/2016)... , Feb. 12, 2016  Aralez Pharmaceuticals Inc. (Nasdaq: ... announced the Company will ring the Nasdaq Closing Bell ... New York at 4:00 p.m. ET on ... Aralez. Adrian Adams , will perform ... 3:50 to 4:00 p.m. ET.  A live webcast will ...
(Date:2/12/2016)... 2016  Apellis Pharmaceuticals, Inc., today announced ... Series D preferred stock financing, co-led by ... Group and venBio Global Strategic Fund, joining ... Investment, and Epidarex Capital. The proceeds of the ... clinical trials in the Company,s ongoing complement ...
Breaking Medicine Technology: